EX-99.1 2 c07893exv99w1.htm EXHIBIT 99.1 Exhibit 99.1
Exhibit 99.1
(NATIONWIDE HEALTH PROPERTIES LOGO)
NATIONWIDE HEALTH PROPERTIES, INC.
REPORTS 2010 THIRD QUARTER RESULTS
   
Adjusted Diluted FFO and FFO per Share Increased 17.9% and 5.4%, Respectively, Over Third Quarter 2009
   
Completed $98 Million of Investments in the Third Quarter of 2010 and $676 Million Year to Date
   
Commenced $53 Million Development Project with PMB
   
Increased Quarterly Dividend to $0.47 Per Share
   
Raising FFO Guidance on the High End of the Range by $0.03 per Share to $2.28
NEWPORT BEACH, CA, — (Marketwire — November 8, 2010) — Nationwide Health Properties, Inc. (NYSE: NHP) today announced results of operations for the third quarter ended September 30, 2010. Contemporaneously with this press release, the Company filed its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2010 with the Securities and Exchange Commission.
“Our third quarter results reflect year to date investments of $676 million, and our pipeline is robust. Compared to the third quarter of 2009, revenue is up 17.6%, adjusted diluted FFO per share is up 5.4% and adjusted diluted FAD per share is up 5.5%. As a result, and for the third consecutive quarter, NHP’s Board of Directors increased our quarterly dividend by $0.01 to $0.47 per share,” commented Douglas M. Pasquale, NHP’s Chairman and Chief Executive Officer. “Our liquidity position remains strong with $116 million in cash and the full complement of our $700 million credit facility at our disposal. Our credit statistics are outstanding, and our diluted FAD payout ratio and FAD coverage are among the strongest in the sector at 79% and 1.26x, respectively,” Mr. Pasquale added.

 

 


 

THIRD QUARTER 2010 RESULTS OF OPERATIONS
The following table presents selected unaudited financial information for the third quarter and nine months ended September 30, 2010 as compared to the same periods of 2009:
Selected Financial Data
($ in thousands, except per share amounts)
                                 
    Three Months Ended September 30,  
    2010     2009     $ Change     % Change  
 
 
Revenue
  $ 114,045     $ 97,011     $ 17,034       17.6 %
Income from Continuing Operations
  $ 36,309     $ 30,924     $ 5,385       17.4 %
Net Income Attributable to NHP Common Stockholders
  $ 39,854     $ 29,692     $ 10,162       34.2 %
Net Income Attributable to NHP Common Stockholders Per Diluted Share
  $ 0.31     $ 0.27     $ 0.04       14.8 %
Diluted FFO
  $ 74,219     $ 63,337     $ 10,882       17.2 %
Adjusted Diluted FFO
  $ 74,254     $ 63,005     $ 11,249       17.9 %
Diluted FFO Per Share
  $ 0.59     $ 0.56     $ 0.03       5.4 %
Adjusted Diluted FFO Per Share
  $ 0.59     $ 0.56     $ 0.03       5.4 %
Diluted FAD
  $ 72,987     $ 62,802     $ 10,185       16.2 %
Adjusted Diluted FAD
  $ 73,022     $ 62,470     $ 10,552       16.9 %
Diluted FAD Per Share
  $ 0.58     $ 0.56     $ 0.02       3.6 %
Adjusted Diluted FAD Per Share
  $ 0.58     $ 0.55     $ 0.03       5.5 %
                                 
    Nine Months Ended September 30,  
    2010     2009     $ Change     % Change  
 
 
Revenue
  $ 324,951     $ 289,957     $ 34,994       12.1 %
Income from Continuing Operations
  $ 100,048     $ 94,355     $ 5,693       6.0 %
Net Income Attributable to NHP Common Stockholders
  $ 108,453     $ 112,145     $ (3,692 )     -3.3 %
Net Income Attributable to NHP Common Stockholders Per Diluted Share
  $ 0.87     $ 1.05     $ (0.18 )     -17.1 %
Diluted FFO
  $ 206,482     $ 191,833     $ 14,649       7.6 %
Adjusted Diluted FFO
  $ 208,891     $ 186,937     $ 21,954       11.7 %
Diluted FFO Per Share
  $ 1.68     $ 1.75     $ (0.07 )     -4.0 %
Adjusted Diluted FFO Per Share
  $ 1.70     $ 1.70     $     0.0 %
Diluted FAD
  $ 203,578     $ 190,770     $ 12,808       6.7 %
Adjusted Diluted FAD
  $ 205,987     $ 185,874     $ 20,113       10.8 %
Diluted FAD Per Share
  $ 1.65     $ 1.74     $ (0.09 )     -5.2 %
Adjusted Diluted FAD Per Share
  $ 1.67     $ 1.69     $ (0.02 )     -1.2 %

 

2


 

NON-GAAP FINANCIAL MEASURES
Diluted Funds From Operations (“FFO”) and Diluted Funds Available for Distribution (“FAD”) are non-GAAP measures that we believe are important to understanding our operations. We believe diluted FFO is an important supplemental measure of operating performance because it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). We believe diluted FAD is an important supplemental measure of operating performance because, like diluted FFO, it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). It also excludes straight-lined rent and other non-cash items that have become more significant for us and our competitors over the last several years. We believe that net income is the most directly comparable GAAP measure to diluted FFO and diluted FAD. Reconciliations between net income and diluted FFO and net income and diluted FAD are included in the accompanying financial data. For guidance, we have also included in the accompanying financial data reconciliations between net income per share and diluted FFO and diluted FAD per share. We have also included adjusted diluted FFO and adjusted diluted FAD amounts which exclude acquisition costs and the recognition of a net gain on re-measurement of equity interest upon acquisition in 2010 and gains on debt extinguishments in 2010 and 2009.
THIRD QUARTER 2010 INVESTMENT ACTIVITY
Investment Activity 2010
($ in thousands)
                                         
    Q1     Q2     Q3     Q4     YTD  
Investment   Total     Total     Total     To Date     Total  
Assisted and Independent Living Facilities
                                       
Investment
          $ 6,000     $ 46,000             $ 52,000  
Initial Yield
            8.8 %     8.2 %             8.3 %
Skilled Nursing Facilities
                                       
Investment
          $ 130,000     $ 47,000     $ 39,000     $ 216,000  
Initial Yield
            9.1 %     9.6 %     11.9 %     9.7 %
Medical Office Buildings
                                       
Investment
  $ 380,000     $ 46,000                     $ 426,000  
Initial Yield
    8.2 %     9.3 %                     8.4 %
Total
                                       
Investment
  $ 380,000     $ 182,000     $ 93,000     $ 39,000     $ 694,000  
Initial Yield
    8.2 %     9.1 %     8.9 %     11.9 %     8.7 %
Additionally in the third quarter of 2010, we invested approximately $5.0 million in revenue producing capital expenditures at a blended yield of 8.4% for a total of $15.0 million at a blended yield of 8.4% in the first nine months of the year. Year to date, we funded two unsecured loans totaling $5.5 million at a blended rate of 9.3%. We also entered into a joint venture with PMB to develop a medical office building in Mission Hills, CA, our first development pursuant to the Amended and Restated Pipeline Property Agreement. We funded $14.7 million in the third quarter for a project with a budget of $53.0 million.

 

3


 

THIRD QUARTER 2010 FINANCING TRANSACTIONS
At-The-Market Equity Offering Program 2010
(in thousands, except price per share)
                                         
    Q1     Q2     Q3     Q4     YTD  
    Total     Total     Total     To Date     Total  
 
 
Number of Shares
    1,269       3,789       2,793       1,290       9,141  
Average Price per Share
  $ 35.58     $ 35.69     $ 37.90     $ 40.59     $ 37.04  
Net Proceeds
  $ 44,673     $ 133,820     $ 104,750     $ 51,820     $ 335,063  
In the third quarter, we paid off $64.3 million of mortgage debt that matured and prepaid $12.4 million of mortgage debt. Subsequent to September 30, 2010, we paid off $70.8 million of mortgage debt that was scheduled to mature within the next 12 months.
Additionally during the third quarter, we entered into six 12-month forward-starting interest rate swap agreements for an aggregate notional amount of $250.0 million at a weighted average rate of 3.16%. We entered into these swap agreements in order to hedge the expected interest payments associated with fixed rate unsecured debt forecasted to be issued in 2011. The swap agreements each have an effective date of August 1, 2011 and a termination date of August 1, 2021. We expect to settle the swap agreements when the forecasted debt is issued. At September 30, 2010, the swap agreements had a negative fair value of $6.0 million.
2010 GUIDANCE
Guidance for Year Ended December 31, 2010
                                         
    Guidance Dates     Change from  
    Initial     Q1 Results     Q2 Results     Current     Previous  
Metric   Guidance     Update     Update     Update     Update  
Adjusted Diluted FFO Per Share
                                       
High End
  $ 2.09     $ 2.17     $ 2.25     $ 2.28     $ 0.03  
Low End
  $ 2.05     $ 2.14     $ 2.23     $ 2.27     $ 0.04  
Adjusted Diluted FAD Per Share
                                       
High End
  $ 2.05     $ 2.13     $ 2.19     $ 2.24     $ 0.05  
Low End
  $ 2.01     $ 2.10     $ 2.17     $ 2.23     $ 0.06  
Our guidance includes shares issued through our at-the-market equity offering program, mortgage debt payoffs and closed acquisitions and dispositions through November 8, 2010; it excludes any other acquisitions, investments, impairments or capital transactions that may occur in the remainder of 2010.

 

4


 

CONFERENCE CALL INFORMATION
We have scheduled a conference call and webcast on Tuesday, November 9, 2010 at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time) to discuss these results. The conference call is accessible by dialing (800) 259-0251 and referencing conference ID number 37726850 or by logging on to our website at http://www.nhp-reit.com. The international dial-in number is (617) 614-3671. The earnings release and any additional financial information that may be discussed on the conference call and webcast will also be available at the same location on our website. A digitized replay of the conference call will be available from 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time) that day until 11:59 p.m. Pacific Time (2:59 a.m. Eastern Time), December 9, 2010. Callers can access the replay by dialing (888) 286-8010 or (617) 801-6888 and entering conference ID number 39698484. Webcast replays will also be available on our website for at least 12 months following the conference call. Our supplemental information package for the quarter ended September 30, 2010 is available on our website, free of charge, at http://www.nhp-reit.com by selecting “Investor Relations” followed by “Financial Information” and is included in our Current Report on Form 8-K filed November 8, 2010 with the SEC also containing this release. Shareholders may receive, free of charge, a complete set of our audited financial statements upon request.
ABOUT NATIONWIDE HEALTH PROPERTIES, INC.
Nationwide Health Properties, Inc. is a real estate investment trust (REIT) that invests primarily in healthcare real estate in the United States. As of September 30, 2010, the Company’s portfolio of properties, including mortgage loans and properties owned by unconsolidated joint ventures, totaled 637 properties among the following segments: 287 senior housing facilities, 211 skilled nursing facilities, 120 medical office buildings, 11 continuing care retirement communities, 7 specialty hospitals and 1 asset in development. For more information on Nationwide Health Properties, Inc., visit our website at http://www.nhp-reit.com.
FORWARD LOOKING STATEMENTS
Certain information contained in this release includes forward-looking statements. Forward-looking statements include statements regarding our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are not statements of historical facts. These statements may be identified, without limitation, by the use of forward-looking terminology such as “may,” “will,” “anticipates,” “expects,” “believes,” “intends,” “should” or comparable terms or the negative thereof. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those described in the statements. Risks and uncertainties associated with our business include (without limitation) the following: deterioration in the operating results or financial condition, including bankruptcies, of our tenants; non-payment or late payment of rent, interest or loan principal amounts by our tenants; our reliance on one tenant for a significant percentage of our revenue; occupancy levels at certain facilities; our level of indebtedness; changes in the ratings of our debt securities; maintaining compliance with our debt covenants; access to the capital markets and the cost and availability of capital;

 

5


 

the effect of healthcare reform legislation or government regulations, including changes in the reimbursement levels under the Medicare and Medicaid programs; the general distress of the healthcare industry; increasing competition in our business sector; the effect of economic and market conditions and changes in interest rates; the amount and yield of any additional investments; risks associated with acquisitions, including our ability to identify and complete favorable transactions, delays or failures in obtaining third party consents or approvals, the failure to achieve perceived benefits, unexpected costs or liabilities and potential litigation; risks associated with development, including our ability to obtain financing, delays or failures in obtaining necessary permits and authorizations, the failure to achieve original project estimates and our limited history in conducting ground-up development projects; the ability of our tenants to pay contractual rent and/or interest escalations in future periods; the ability of our tenants to obtain and maintain adequate liability and other insurance; our ability to attract new tenants for certain facilities; our ability to sell certain facilities for their book value; our ability to retain key personnel; potential liability under environmental laws; the possibility that we could be required to repurchase some of our senior notes; changes in or inadvertent violations of tax laws and regulations and other factors that can affect our status as a real estate investment trust; and other factors discussed from time to time in our news releases, public statements and/or filings with the Securities and Exchange Commission, especially the “Risk Factors” sections of our Annual and Quarterly Reports on Forms 10-K and 10-Q. Forward-looking information is provided by us pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. We disclaim any intent or obligation to update these forward-looking statements.
Contact:
Abdo H. Khoury
Chief Financial and Portfolio Officer
Nationwide Health Properties, Inc.
(949) 718-4400
***Financial Tables to Follow***

 

6


 

NATIONWIDE HEALTH PROPERTIES, INC.
CONSOLIDATED INCOME STATEMENTS
(In thousands, except per share data)
(Unaudited)
                                 
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2010     2009     2010     2009  
Revenue:
                               
Triple-net lease rent
  $ 80,123     $ 72,675     $ 229,369     $ 218,105  
Medical office building operating rent
    26,868       17,588       75,677       52,111  
 
                       
 
    106,991       90,263       305,046       270,216  
Interest and other income
    7,054       6,748       19,905       19,741  
 
                       
 
    114,045       97,011       324,951       289,957  
 
                               
Expenses:
                               
Interest expense
    23,782       23,221       71,824       70,540  
Depreciation and amortization
    36,204       30,625       101,734       91,721  
General and administrative
    7,902       6,514       22,262       20,404  
Acquisition costs
    35             3,104        
Medical office building operating expenses
    11,192       7,240       30,109       21,201  
 
                       
 
    79,115       67,600       229,033       203,866  
 
                       
Operating income
    34,930       29,411       95,918       86,091  
Income from unconsolidated joint ventures
    1,379       1,513       4,055       3,700  
Gain on debt extinguishment
                75       4,564  
 
                       
Income from continuing operations
    36,309       30,924       100,048       94,355  
Discontinued operations:
                               
Gains on sale of facilities, net
    2,686             6,487       21,152  
Income from discontinued operations
    301       301       1,023       1,177  
 
                       
 
    2,987       301       7,510       22,329  
 
                       
Net income
    39,296       31,225       107,558       116,684  
Net loss (income) attributable to noncontrolling interests
    558       (82 )     895       (184 )
 
                       
Net income attributable to NHP
    39,854       31,143       108,453       116,500  
Preferred stock dividends
          (1,451 )           (4,355 )
 
                       
Income available to NHP common stockholders
  $ 39,854     $ 29,692     $ 108,453     $ 112,145  
 
                       
 
                               
Basic earnings per share (EPS):
                               
Income from continuing operations attributable to NHP common stockholders
  $ 0.30     $ 0.27     $ 0.83     $ 0.86  
Discontinued operations attributable to NHP common stockholders
    0.02       0.01       0.06       0.21  
 
                       
Net income attributable to NHP common stockholders
  $ 0.32     $ 0.28     $ 0.89     $ 1.07  
 
                       
 
                               
Diluted EPS:
                               
Income from continuing operations attributable to NHP common stockholders
  $ 0.29     $ 0.27     $ 0.81     $ 0.84  
Discontinued operations attributable to NHP common stockholders
    0.02             0.06       0.21  
 
                       
Net income attributable to NHP common stockholders
  $ 0.31     $ 0.27     $ 0.87     $ 1.05  
 
                       
 
                               
Weighted average shares outstanding for EPS:
                               
Basic
    123,721       107,175       120,242       104,224  
 
                       
Diluted
    126,497       109,477       122,878       106,389  
 
                       

 

7


 

NATIONWIDE HEALTH PROPERTIES, INC.
RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
(In thousands, except per share data)
(Unaudited)
Reconciliation of Net Income to Adjusted Diluted FFO
                                 
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2010     2009     2010     2009  
 
 
Net income
  $ 39,296     $ 31,225     $ 107,558     $ 116,684  
Preferred stock dividends
          (1,451 )           (4,355 )
Net loss (income) attributable to noncontrolling interests
    558       (82 )     895       (184 )
Real estate related depreciation and amortization
    35,863       30,875       100,908       92,548  
Depreciation in income from unconsolidated joint ventures
    1,188       1,319       3,608       3,937  
Gains on sale of facilities, net
    (2,686 )           (6,487 )     (21,152 )
 
                       
FFO available to NHP common stockholders
    74,219       61,886       206,482       187,478  
Series B preferred dividend add-back
          1,451             4,355  
 
                       
Diluted FFO
    74,219       63,337       206,482       191,833  
Acquisition costs
    35             3,104        
Gain on extinguishment of debt
          (332 )     (75 )     (4,896 )
Gain on re-measurement of equity interest upon acquisition, net
                (620 )      
 
                       
Adjusted diluted FFO
  $ 74,254     $ 63,005     $ 208,891     $ 186,937  
 
                       
 
                               
Weighted average shares outstanding for diluted FFO:
                               
Diluted weighted average shares outstanding (1)
    126,586       109,568       122,980       106,433  
Series B preferred stock conversion add-back if not already converted
          3,375       102       3,367  
 
                       
Fully diluted weighted average shares outstanding
    126,586       112,943       123,082       109,800  
 
                       
 
                               
Diluted FFO per share
  $ 0.59     $ 0.56     $ 1.68     $ 1.75  
 
                       
Adjusted diluted FFO per share
  $ 0.59     $ 0.56     $ 1.70     $ 1.70  
 
                       
 
                               
Dividends declared per common share
  $ 0.46     $ 0.44     $ 1.35     $ 1.32  
 
                       
 
                               
Adjusted diluted FFO payout ratio
    78 %     79 %     79 %     78 %
 
                       
Adjusted diluted FFO coverage
    1.28       1.27       1.26       1.29  
 
                       
     
(1)  
Diluted weighted average shares outstanding includes the effect of all participating and non-participating share-based payment awards which for us consists of stock options and other share-based payment awards if the effect is dilutive. The dilutive effect of all share-based payment awards is calculated using the treasury stock method. Additionally, our redeemable OP units are included as if converted to common stock on a one-for-one basis.

 

8


 

NATIONWIDE HEALTH PROPERTIES, INC.
RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
(In thousands, except per share data)
(Unaudited)
Reconciliation of Net Income to Adjusted Diluted FAD
                                 
         
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2010     2009     2010     2009  
 
 
Net income
  $ 39,296     $ 31,225     $ 107,558     $ 116,684  
Preferred stock dividends
          (1,451 )           (4,355 )
Net loss (income) attributable to noncontrolling interests
    558       (82 )     895       (184 )
Real estate related depreciation and amortization
    35,863       30,875       100,908       92,548  
Gains on sale of facilities, net
    (2,686 )           (6,487 )     (21,152 )
Straight-lined rent
    (2,867 )     (1,578 )     (8,066 )     (4,766 )
Amortization of intangible assets and liabilities
    116       (139 )     207       (408 )
Non-cash stock-based compensation expense
    1,749       1,816       5,174       5,226  
Deferred financing cost amortization
    1,090       766       2,764       2,336  
Lease commissions and tenant and capital improvements
    (1,354 )     (1,407 )     (3,057 )     (3,476 )
Unconsolidated joint ventures:
                               
Real estate related depreciation and amortization
    1,188       1,319       3,608       3,937  
Straight-lined rent
    9       (19 )     6       (43 )
Amortization of intangible assets and liabilities
          5             5  
Deferred finance cost amortization
    25       21       68       63  
 
                       
FAD available to NHP common stockholders
    72,987       61,351       203,578       186,415  
Series B preferred dividends
          1,451             4,355  
 
                       
Diluted FAD
    72,987       62,802       203,578       190,770  
Acquisition costs
    35             3,104        
Gain on extinguishment of debt
          (332 )     (75 )     (4,896 )
Gain on re-measurement of equity interest upon acquisition, net
                (620 )      
 
                       
Adjusted diluted FAD
  $ 73,022     $ 62,470     $ 205,987     $ 185,874  
 
                       
 
                               
Weighted average shares outstanding for diluted FAD:
                               
Diluted weighted average shares outstanding (1)
    126,586       109,568       122,980       106,433  
Series B preferred stock add-back if not already converted
          3,375       102       3,367  
 
                       
Fully diluted weighted average shares outstanding
    126,586       112,943       123,082       109,800  
 
                       
 
                               
Diluted FAD per share
  $ 0.58     $ 0.56     $ 1.65     $ 1.74  
 
                       
Adjusted diluted FAD per share
  $ 0.58     $ 0.55     $ 1.67     $ 1.69  
 
                       
 
 
Dividends declared per common share
  $ 0.46     $ 0.44     $ 1.35     $ 1.32  
 
                       
 
                               
Adjusted diluted FAD payout ratio
    79 %     80 %     81 %     78 %
 
                       
Adjusted diluted FAD coverage
    1.26       1.25       1.24       1.28  
 
                       
     
(1)  
Diluted weighted average shares outstanding includes the effect of all participating and non-participating share-based payment awards which for us consists of stock options and other share-based payment awards if the effect is dilutive. The dilutive effect of all share-based payment awards is calculated using the treasury stock method. Additionally, our redeemable OP units are included as if converted to common stock on a one-for-one basis.

 

9


 

NATIONWIDE HEALTH PROPERTIES, INC.
RECONCILIATION OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
(In thousands, except per share data)
2010 Guidance Reconciliation of Net Income to Adjusted Diluted FFO and FAD Per Share
                 
    Year Ended December 31, 2010  
    Guidance  
    Low     High  
 
               
Net income
  $ 150,271     $ 151,521  
Preferred stock dividends
           
Real estate related depreciation and amortization
    132,194       132,194  
Depreciation in income from unconsolidated joint ventures
    4,781       4,781  
Net loss attributable to noncontrolling interests
    1,047       1,047  
Gains on sales of facilities, net
    (7,999 )     (7,999 )
 
           
FFO available to common stockholders
    280,294       281,544  
Series B preferred dividends
           
 
           
Diluted FFO
    280,294       281,544  
Acquisition costs
    3,105       3,105  
Gain on extinguishment of debt
    (75 )     (75 )
Gain on re-measurement of equity interest upon acquisition, net
    (620 )     (620 )
 
           
Adjusted Diluted FFO
    282,704       283,954  
Straight-lined rent
    (10,784 )     (10,784 )
Amortization of intangible assets and liabilities
    131       131  
Non-cash stock-based compensation expense
    6,888       6,888  
Deferred financing cost amortization
    3,532       3,532  
Lease commissions and tenant and capital improvements
    (4,968 )     (4,968 )
Unconsolidated Joint Ventures:
               
Straight-lined rent
    8       8  
Deferred financing cost amortization
    89       89  
 
           
Adjusted Diluted FAD
  $ 277,600     $ 278,850  
 
           
 
               
Diluted FFO per share
  $ 2.25     $ 2.26  
 
           
Adjusted Diluted FFO per share
  $ 2.27     $ 2.28  
 
           
Adjusted Diluted FAD per share
  $ 2.23     $ 2.24  
 
           
 
               
Weighted average shares outstanding:
               
Diluted weighted average shares outstanding
    122,268       122,268  
NHP/PMB OP units
    2,134       2,134  
 
           
Total
    124,402       124,402  
 
           

 

10


 

NATIONWIDE HEALTH PROPERTIES, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands)
                 
    September 30,     December 31,  
    2010     2009  
    (unaudited)        
Assets
               
Investments in real estate:
               
Land
  $ 332,379     $ 318,457  
Buildings and improvements
    3,553,712       3,088,183  
Development in progress
    16,195        
 
           
 
    3,902,286       3,406,640  
Less accumulated depreciation
    (655,619 )     (585,294 )
 
           
 
    3,246,667       2,821,346  
Mortgage loans receivable, net
    238,926       110,613  
Mortgage loan receivable from related party
          47,500  
Investments in unconsolidated joint ventures
    42,824       51,924  
 
           
Net real estate related investments
    3,528,417       3,031,383  
Cash and cash equivalents
    116,173       382,278  
Receivables, net
    6,497       6,605  
Intangible assets
    146,572       93,657  
Other assets
    149,034       133,152  
 
           
Total assets
  $ 3,946,693     $ 3,647,075  
 
           
 
               
Liabilities and Equity
               
Unsecured senior credit facility
  $     $  
Senior notes
    991,633       991,633  
Notes and bonds payable
    454,779       431,456  
Accounts payable and accrued liabilities
    140,314       132,915  
 
           
Total liabilities
    1,586,726       1,556,004  
 
               
Redeemable OP unitholder interests
    84,688       57,335  
 
               
Equity:
               
NHP stockholders’ equity:
               
Series B convertible preferred stock
          51,364  
Common stock
    12,495       11,432  
Capital in excess of par value
    2,458,235       2,128,843  
Cumulative net income
    1,813,732       1,705,279  
Accumulated other comprehensive loss
    (9,211 )     (823 )
Cumulative dividends
    (2,027,078 )     (1,862,996 )
 
           
Total NHP stockholders’ equity
    2,248,173       2,033,099  
Noncontrolling interests
    27,106       637  
 
           
Total equity
    2,275,279       2,033,736  
 
           
Total liabilities and equity
  $ 3,946,693     $ 3,647,075  
 
           

 

11